Table: begin end state 1 30 cytoplasmic 31 50 transmembrane 51 55 non-cytoplasmic 56 80 transmembrane 81 91 cytoplasmic 92 111 transmembrane 112 117 non-cytoplasmic 118 137 transmembrane 138 156 cytoplasmic 157 180 transmembrane 181 191 non-cytoplasmic 192 211 transmembrane 212 248 cytoplasmic 249 271 transmembrane 272 282 non-cytoplasmic 283 303 transmembrane 304 314 cytoplasmic 315 332 transmembrane 333 337 non-cytoplasmic 338 359 transmembrane 360 376 cytoplasmic 377 399 transmembrane 400 405 non-cytoplasmic 406 426 transmembrane 427 466 cytoplasmic
Input: >WP_038212448.1 NCBI__GCF_000745855.1:WP_038212448.1 MSSTVTAHEPQGRHQSKKAAASGWIGSALEYYDFFIYATAAALVFPQIFFPKGDPAIAII ASLATYGVGYVARPIGAFVLGHLGDTHGRKQVLVWCMFLMGFSTIAVGLLPTYEQVGLLA PTLLVLMRLIQGFAVAGEISGASSMILEHAPFGRRGFFASFTLQGVQAGQILAAAVFLPL AHYMPTEQFNSWGWRIPFILSFVVIVAGWIIRREVAETPAFTDKSALKERARSPIVDAFK YSTPDMLRVVCMALMNVIPVVATIFGAAYAVQPAYGIGFEKDVYLWIPVLGNILAVLVIP YVGNLSDRIGRRPPIIVGSLLAGLLAFGYLYAISIKNVPLAICMSLLMWGIVYQGYNAVF PSFYPELFPTRTRVSAMAISQNLGTAITAMLPALFTAVAPPGASNIWLTVGAIAFGITVI AALAALSARETYRVHMNDLGRPDAQPVDKAEYDRLRAASMAAAQPA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server